アレルゲン免疫療法の世界市場2019-2023

【英語タイトル】Global Allergy Immunotherapies Market 2019-2023

Technavioが出版した調査資料(IRTNTR30261)・商品コード:IRTNTR30261
・発行会社(調査会社):Technavio
・発行日:2018年11月13日
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、アレルゲン免疫療法の世界市場について調査・分析し、市場概要、市場環境、アレルゲン免疫療法市場規模、製品別(SCIT、SLIT)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・アレルゲン免疫療法の世界市場概要
・アレルゲン免疫療法の世界市場環境
・アレルゲン免疫療法の世界市場動向
・アレルゲン免疫療法の世界市場規模
・アレルゲン免疫療法の世界市場:業界構造分析
・アレルゲン免疫療法の世界市場:製品別(SCIT、SLIT)
・アレルゲン免疫療法の世界市場:地域別市場規模・分析
・アレルゲン免疫療法の北米市場規模・予測
・アレルゲン免疫療法のヨーロッパ・中東・アフリカ市場規模・予測
・アレルゲン免疫療法のアジア太平洋市場規模・予測
・アレルゲン免疫療法の主要国分析
・アレルゲン免疫療法の世界市場:意思決定フレームワーク
・アレルゲン免疫療法の世界市場:成長要因、課題
・アレルゲン免疫療法の世界市場:競争環境
・アレルゲン免疫療法の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

112 pages, November 2018
About this market
The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Technavio’s analysts have predicted that the allergy immunotherapies market will register a CAGR of more than 7% by 2023.
Market Overview
Increasing prevalence of various types of allergies
The increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.
Unknown pathogenesis
The Unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.
For the detailed list of factors that will drive and challenge the growth of the allergy immunotherapies market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be concentrated and with the presence of few companies including ALK and Allergy Therapeutics the competitive environment is quite intense. Factors such as the emerging drug development technologies and the technological advances in allergy diagnostics, will provide considerable growth opportunities to allergy immunotherapies manufactures. ALK, Allergy Therapeutics, Stallergenes Greer, HAL Allergy, and Merck are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors.’

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
A. PIPELINE
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• SCIT – Market size and forecast 2018-2023
• SLIT – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• EMEA – Market size and forecast 2018-2023
• Americas – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALK
• Allergy Therapeutics
• HAL Allergy
• Merck
• Stallergenes Greer
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global immunology treatment market
Exhibit 02: Segments of global immunology treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Global allergy immunotherapies market: Overview
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Global allergy immunotherapies market pipeline: Overview
Exhibit 19: Global allergy immunotherapies market pipeline: Overview
Exhibit 20: Product – Market share 2018-2023 (%)
Exhibit 21: Comparison by product
Exhibit 22: SCIT – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: SCIT – Year-over-year growth 2019-2023 (%)
Exhibit 24: Opportunity analysis of global SCIT market
Exhibit 25: SLIT – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: SLIT – Year-over-year growth 2019-2023 (%)
Exhibit 27: Opportunity analysis of global SLIT market
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 34: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 36: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Geographical presence of few prominent vendors 2018
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: ALK – Vendor overview
Exhibit 48: ALK – Business segments
Exhibit 49: ALK – Organizational developments
Exhibit 50: ALK – Geographic focus
Exhibit 51: ALK – Key offerings
Exhibit 52: ALK – Key customers
Exhibit 53: Allergy Therapeutics – Vendor overview
Exhibit 54: Allergy Therapeutics – Business segments
Exhibit 55: Allergy Therapeutics – Organizational developments
Exhibit 56: Allergy Therapeutics – Segment focus
Exhibit 57: Allergy Therapeutics – Key offerings
Exhibit 58: Allergy Therapeutics – Key customers
Exhibit 59: HAL Allergy – Vendor overview
Exhibit 60: HAL Allergy – Business segments
Exhibit 61: HAL Allergy – Organizational developments
Exhibit 62: HAL Allergy – Key offerings
Exhibit 63: HAL Allergy – Key customers
Exhibit 64: Merck – Vendor overview
Exhibit 65: Merck – Business segments
Exhibit 66: Merck – Organizational developments
Exhibit 67: Merck – Geographic focus
Exhibit 68: Merck – Segment focus
Exhibit 69: Merck – Key offerings
Exhibit 70: Merck – Key customers
Exhibit 71: Stallergenes Greer – Vendor overview
Exhibit 72: Stallergenes Greer – Business segments
Exhibit 73: Stallergenes Greer – Organizational developments
Exhibit 74: Stallergenes Greer – Geographic focus
Exhibit 75: Stallergenes Greer – Key offerings
Exhibit 76: Stallergenes Greer – Key customers




【掲載企業】

ALK、Allergy Therapeutics、HAL Allergy、Merck、Stallergenes Greer

★調査レポート[アレルゲン免疫療法の世界市場2019-2023] (コード:IRTNTR30261)販売に関する免責事項を必ずご確認ください。
★調査レポート[アレルゲン免疫療法の世界市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆